DNA methylation, field effects, and colorectal cancer

Journal of the National Cancer Institute

Volumn 97, Issue 18, 2005, Pages 1317-1319

  Giovannucci, Edward ^a,b,c   Ogino, Shuji ^b,c,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DANA FARBER HARVARD CANCER CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADENINE; CHOLINE; DNA POLYMERASE; FOLIC ACID; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTECTIVE AGENT; TUMOR MARKER;

CANCER PREVENTION; CANCER RISK; CARBON METABOLISM; COLON CARCINOGENESIS; COLON MUCOSA; COLONOSCOPY; COLORECTAL CANCER; DIET; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE PREDISPOSITION; DNA METHYLATION; EARLY DIAGNOSIS; EDITORIAL; GENE MUTATION; GENE SILENCING; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE METABOLISM; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; COLORECTAL TUMOR; ENZYMOLOGY; GENETICS; INTESTINE MUCOSA; NOTE; PATHOLOGY;

COLORECTAL NEOPLASMS; DNA METHYLATION; GENE SILENCING; HUMANS; INTESTINAL MUCOSA; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PROMOTER REGIONS (GENETICS); TUMOR MARKERS, BIOLOGICAL;

EID: 25144474539     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dji305     Document Type: Editorial

References (27)

1. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953;6:963-8.
2. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
3. Franklin WA, Gazdar AF, Haney J, Wistuba II, La Rosa FG, Kennedy T, et al. Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J Clin Invest 1997;100:2133-7.
4. Prevo LJ, Sanchez CA, Galipeau PC, Reid BJ. p53-mutant clones and field effects in Barrett's esophagus. Cancer Res 1999;59:4784-7.
5. Rosenthal AN, Ryan A, Hopster D, Jacobs IJ. Molecular evidence of a common clonal origin and subsequent divergent clonal evolution in vulval intraepithelial neoplasia, vulval squamous cell carcinoma and lymph node metastases. Int J Cancer 2002;99:549-54.
6. Chu TY, Shen CY, Lee HS, Liu HS. Monoclonality and surface lesion-specific microsatellite alterations in premalignant and malignant neoplasia of uterine cervix: A local field effect of genomic instability and clonal evolution. Genes Chromosomes Cancer 1999;24:127-34.
7. Takahashi T, Habuchi T, Kakehi Y, Mitsumori K, Akao T, Terachi T, et al. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract. Cancer Res 1998;58:5835-41.
8. Eads CA, Lord RV, Kurumboor SK, Wickramasinghe K, Skinner ML, Long TI, et al. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res 2000;60: 5021-6.
9. Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 2001;61:3573-7.
10. Habuchi T, Takahashi T, Kakinuma H, Wang L, Tsuchiya N, Satoh S, et al. Hypermethylation at 9q32-33 tumour suppressor region is age-related in normal urothelium and an early and frequent alteration in bladder cancer. Oncogene 2001;20:531-7.
11. Tamura G. Promoter methylation status of tumor suppressor and tumor-related genes in neoplastic and non-neoplastic gastric epithelia. Histol Histopathol 2004;19:221-8.
12. Guo M, House MG, Hooker C, Han Y, Heath E, Gabrielson E, et al. Promoter hypermethylation of resected bronchial margins: A field defect of changes? Clin Cancer Res 2004;10:5131-6.
13. Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, et al. MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 2005;97:1330-8.
14. Pegg AE. Mammalian O6-alkylguanine-DNA alkyltransferase: Regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res 1990;50:6119-29.
15. Pegg AE, Byers TL. Repair of DNA containing O6-alkylguanine. FASEB J 1992;6:2302-10.
16. Nagasaka T, Sharp GB, Notohara K, Kambara T, Sasamoto H, Isozaki H, et al. Hypermethylation of O(6)-methylguanine-DNA methyltransferase promoter may predict nonrecurrence after chemotherapy in colorectal cancer cases. Clin Cancer Res 2003;9:5306-12.
17. Esteller M, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Watkins DN, et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 2000;60:2368-71.
18. Esteller M, Risques RA, Toyota M, Capella G, Moreno V, Peinado MA, et al. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res 2001;61:4689-92.
19. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 1997;57:808-11.
20. Kim YI, Pogribny IP, Salomon RN, Choi SW, Smith DE, James SJ, et al. Exon-specific DNA hypomethylation of the p53 gene of rat colon induced by dimethylhydrazine. Am J Pathol 1996;149:1129-37.
21. Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 2002;132:2350S-5S.
22. Friso S, Choi SW. Gene-nutrient interactions in one-carbon metabolism. Curr Drug Metab 2005;6:37-46.
23. Martinez ME, Maltzman T, Marshall JR, Einspahr J, Reid ME, Sampliner R, et al. Risk factors for Ki-ras protooncogene mutation in sporadic colorectal adenomas. Cancer Res 1999;59:5181-5.
24. Slattery ML, Curtin K, Anderson K, Ma KN, Edwards S, Leppert M, et al. Associations between dietary intake and Ki-ras mutations in colon tumors: A population-based study. Cancer Res 2000;60:6935-41.
25. Brink M, Weijenberg MP, de Goeij AF, Roemen GM, Lentjes MH, de Bruine AP, et al. Dietary folate intake and k-ras mutations in sporadic colon and rectal cancer in The Netherlands Cohort Study. Int J Cancer 2005;114:824-30.
26. Kim YI. Folate, colorectal carcinogenesis, and DNA methylation: Lessons from animal studies. Environ Mol Mutagen 2004;44:10-25.
27. Giovannucci E, Stampfer MJ, Colditz GA, Hunter DJ, Fuchs C, Rosner BA, et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 1998;129:517-24.